Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -3.79%104.25M | 21.26%369.75M | 3.01%95.02M | 3.74%83.83M | 34.05%82.54M | 54.15%108.36M | -8.45%304.92M | 18.02%92.24M | 6.63%80.81M | -20.28%61.57M |
| Cost of revenue | -3.04%92.57M | 4.31%314M | -15.65%80.95M | -8.35%69.64M | 7.04%67.94M | 45.56%95.47M | -6.45%301.02M | 29.34%95.97M | 6.19%75.99M | -17.30%63.47M |
| Gross profit | -9.29%11.69M | 1,328.75%55.75M | 478.01%14.08M | 194.54%14.19M | 870.34%14.6M | 173.87%12.88M | -65.45%3.9M | -194.03%-3.72M | 14.12%4.82M | -485.16%-1.9M |
| Operating expense | -42.40%4.4M | 33.37%24.16M | 11.34%5.89M | 41.23%4.81M | -19.19%2.69M | 60.26%7.64M | 14.94%18.11M | -52.47%5.29M | 119.27%3.4M | 163.81%3.32M |
| Selling and administrative expenses | 28.41%3.87M | 13.62%13.22M | 23.71%3.77M | 28.84%3.33M | 11.51%3.1M | -6.33%3.02M | 6.25%11.63M | -4.39%3.05M | 17.62%2.58M | 17.01%2.78M |
| -General and administrative expense | 28.41%3.87M | 13.62%13.22M | 23.71%3.77M | 28.84%3.33M | 11.51%3.1M | -6.33%3.02M | 6.25%11.63M | -4.39%3.05M | 17.62%2.58M | 17.01%2.78M |
| Other operating expenses | -73.79%1.96M | 49.60%13.14M | 37.77%3.33M | -11.47%2.05M | -77.77%426K | 230.48%7.46M | 13.25%8.78M | 19.95%2.42M | 0.61%2.31M | -4.53%1.92M |
| Total other operating income | -49.63%1.43M | -4.48%2.2M | 589.20%1.21M | -61.90%568K | -38.80%839K | 299.58%2.83M | -21.78%2.31M | 102.97%176K | -49.30%1.49M | -56.09%1.37M |
| Operating profit | 39.01%7.28M | 322.32%31.59M | 190.76%8.18M | 563.51%9.38M | 328.24%11.91M | 8,161.54%5.24M | -218.16%-14.21M | -25.65%-9.02M | -47.02%1.41M | -579.56%-5.22M |
| Net non-operating interest income (expenses) | -52.93%450K | -24.25%3.13M | -45.20%559K | -30.16%762K | -16.62%848K | -4.11%956K | 49.50%4.13M | -70.61%1.02M | 493.86%1.09M | 556.05%1.02M |
| Non-operating interest income | -46.16%617K | -23.48%3.92M | -41.01%745K | -28.21%952K | -15.46%1.08M | -9.05%1.15M | 37.28%5.12M | --1.26M | --1.33M | --1.27M |
| Non-operating interest expense | -12.11%167K | -20.30%795.32K | -23.46%186K | -19.15%190K | -10.89%229K | -27.76%190K | 2.60%997.89K | -7.10%243K | -15.16%235K | 15.25%257K |
| Net investment income | 15.96%109K | 119.40%715.44K | 21.74%112K | 5.41%78K | 100.00%16K | -38.16%94K | -95.16%326.09K | 92K | 74K | 8K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 8,919.23%4.69M | -131.89%-2.4M | -107.02%-280K | -214.97%-3.09M | 596.22%918K | -94.94%52K | 1,012.79%7.52M | 457.70%3.99M | 22.05%2.69M | -109.53%-185K |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 4.76%-120K | 105.44%2.13M | -97.66%7K | 0.00%-120K | -5.00%-126K | -25.51%1.04M | -82.84%299K | -9.09%-120K | ||
| Less:Other special charges | ---- | -127.18%-2.49M | ---- | ---- | ---- | ---- | ---1.1M | ---- | ---- | ---- |
| Less:Write off | -4.76%120K | 498.66%363.31K | 97.66%-7K | 0.00%120K | ---- | 5.00%126K | 104.36%60.69K | 82.84%-299K | 9.09%120K | ---- |
| Other non-operating income (expenses) | -0.48%342.09K | 22.45%343.76K | ||||||||
| Income before tax | 99.69%12.41M | 4,227.08%35.51M | 337.33%8.58M | 36.37%7.02M | 412.72%13.69M | 212.20%6.22M | -114.62%-860.35K | -191.65%-3.62M | 14.77%5.14M | -560.46%-4.38M |
| Income tax | -38.59%1.4M | 68.56%6.93M | -0.07%1.5M | 126.81%1.88M | 29.15%1.27M | 185.38%2.28M | -48.65%4.11M | -81.52%1.5M | 1.35%828K | 220.81%981K |
| Net income | 179.96%11.01M | 674.88%28.58M | 238.35%7.08M | 19.02%5.14M | 331.85%12.43M | 230.23%3.93M | -134.55%-4.97M | -22.40%-5.12M | 17.76%4.32M | -404.03%-5.36M |
| Net income continuous operations | 179.96%11.01M | 674.88%28.58M | 238.35%7.08M | 19.02%5.14M | 331.85%12.43M | 230.23%3.93M | -134.55%-4.97M | -22.40%-5.12M | 17.76%4.32M | -404.03%-5.36M |
| Noncontrolling interests | 0 | 0 | ||||||||
| Net income attributable to the company | 179.96%11.01M | 674.88%28.58M | 238.35%7.08M | 19.02%5.14M | 331.85%12.43M | 230.23%3.93M | -134.55%-4.97M | -22.40%-5.12M | 17.76%4.32M | -404.03%-5.36M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 179.96%11.01M | 674.88%28.58M | 238.35%7.08M | 19.02%5.14M | 331.85%12.43M | 230.23%3.93M | -134.55%-4.97M | -22.40%-5.12M | 17.76%4.32M | -404.03%-5.36M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 175.00%0.066 | 674.33%0.1723 | 235.48%0.042 | 19.23%0.031 | 334.38%0.075 | 242.86%0.024 | -134.38%-0.03 | -25.00%-0.031 | 18.18%0.026 | -420.00%-0.032 |
| Diluted earnings per share | 175.00%0.066 | 674.33%0.1723 | 235.48%0.042 | 19.23%0.031 | 334.38%0.075 | 242.86%0.024 | -134.38%-0.03 | -25.00%-0.031 | 18.18%0.026 | -420.00%-0.032 |
| Dividend per share | 0 | 66.67%0.05 | 0 | 0 | 66.67%0.05 | 0 | -62.50%0.03 | 0 | 0 | -50.00%0.03 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.